News
German vaccine maker BioNTech said on Tuesday that it plans to invest up to 1 billion pounds ($1.33 billion) over the next ...
Roughly five months after AstraZeneca scrapped a major investment plan in its home country, the United Kingdom has found a ...
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
Biopharmaceutical company BioNTech has announced funding of up to £1 billion into the United Kingdom over the next 10 years.
After delays, the FDA has greenlit the Novavax COVID vaccine for targeted groups. Learn more about the approval and what it ...
Vaccine advisers to the FDA decided Thursday that only strains of the JN.1 variant should be targeted by updated versions of covid vaccines that will be available next fall and winter. Separately, ...
The agreement between BioNTech’s subsidiary BioNTech UK and the UK government is focused on accelerating clinical trials for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results